$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > 鲁可欣

地舒单抗(鲁可欣)|上市信息

齐鲁制药地舒单抗注射液(鲁可欣)获批上市
  • 齐鲁制药地舒单抗注射液(鲁可欣)获批上市
  • 近日,齐鲁制药生物类似药地舒单抗注射液(鲁可欣)获得国家药品监督管理局上市批准,用于骨折高风险的绝经后妇女的骨质疏松症。在绝经后妇女中,本品可显著降低椎体、非椎体和髋部骨...|阅读全文
  • 发布日期 2023-10-26 22:45:16